Last Updated: March, 2026
Trusted by 200+ Clients
Compare & Choose the Right Report Version for You
How to Order Your Report?
The report provides a detailed analysis essential for establishing an oteseconazole production plant. It encompasses all critical aspects necessary for oteseconazole production, including the cost of oteseconazole production, oteseconazole plant cost, oteseconazole production costs, and the overall oteseconazole production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an oteseconazole production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Oteseconazole is an advanced oral antifungal medication that is used to fight recurrent vulvovaginal candidiasis (RVVC). It is a frequent vaginal yeast infection caused by Candida species in postmenopausal women. It is also used in women who have undergone hysterectomy, ovary removal, or tubal ligation to eliminate pregnancy risk. It works by stopping the fungal CYP51 enzyme, which disrupts ergosterol synthesis essential for fungal cell membrane integrity, effectively killing the yeast while having minimal impact on human cells. It is utilised in patients who are unresponsive to standard fluconazole, offering potent activity against resistant strains like Candida glabrata and albicans. Its common side effects include headache, nausea, abdominal discomfort, hot flashes, and elevated creatine phosphokinase, generally mild with low discontinuation rates.
The market for oteseconazole is influenced by its FDA approval as the first treatment for recurrent vulvovaginal candidiasis (RVVC). Its utilisation among non-reproductive-age females with superior long-term efficacy that reduces recurrences versus placebo contributes to its market growth. The rising fungal resistance to older azoles like fluconazole and growing awareness of RVVC fuel its demand. The reliance on GMP-certified API and high R&D and pricing premiums because of orphan-like status affects industrial oteseconazole procurement. The regulatory hurdles (FDA/EMA approvals), reimbursement based on proven recurrence prevention and low interactions, along with licensing deals ensuring stable regional access while limiting generics impacts its sourcing strategies.
According to the oteseconazole production plant project report, the key raw materials used in the production of oteseconazole include (R)-2-amino-2-(2,4-difluorophenyl)-1-(4-bromopyridin-2-yl)ethanol, potassium carbonate, and 4-(trifluoromethoxy)phenylboronic acid.
The extensive oteseconazole production cost report consists of the following major industrial production process:
From (R)-2-amino-2-(2,4-difluorophenyl)-1-(4-bromopyridin-2-yl)ethanol: The synthesis of oteseconazole starts with enantiomerically enriched (R)-2-amino-2-(2,4-difluorophenyl)-1-(4-bromopyridin-2-yl)ethanol. It is obtained via resolution with L-di-p-toluoyl-tartaric acid. The chiral salt is basified using potassium carbonate to liberate the free amino alcohol. This intermediate goes through a palladium-catalysed Suzuki–Miyaura coupling with 4-(trifluoromethoxy)phenylboronic acid to construct the biaryl pyridine framework. The coupled product is then subjected to tetrazole ring formation using trimethylsilyl azide under acidic conditions with trimethyl orthoformate, forming the tetrazole moiety. Finally, the product is purified by recrystallisation from ethanol and n-heptane to obtain oteseconazole.
Oteseconazole has the molecular formula of C23H16F7N5O2 with a molecular weight of 527.4 g/mol. It is a white to off-white solid with high lipophilicity, with a cLogP value in the range 4.6–5.0. It has low aqueous solubility and good permeability suited for oral capsules, featuring a tetrazole antifungal warhead, difluorophenyl ring, and trifluoroethoxyphenyl-pyridine core. It has one chiral centre ((R)-configuration), a polar surface area of around 86 Ų, one H-bond donor, seven acceptors, eight rotatable bonds, and four aromatic rings. It has metabolic stability, minimal host enzyme inhibition, and favourable pharmacokinetics despite heptafluorination enhancing potency against Candida.
Oteseconazole Production Cost Report
Choose What's Right for You
Pay Via
| Particulars | Details |
|---|---|
| Product Name | Oteseconazole |
| Scope | Production Process: Process Flow, Material Flow, Material Balance Raw Material and Product Specifications: Raw Material Consumption, Product and Co-product Generation Land and Site Cost: Offsites/Civil Works, Equipment Cost, Auxiliary Equipment Costs, Contingency, Engineering and Consulting Charges, Working Capital Variable Cost: Raw Material, Utilities, Other Variable Costs Fixed Cost: Labor Requirements and Wages, Overhead Expenses, Maintenance Charges, Other Fixed Costs Financing Costs: Interest on Working Capital, Interest on Loans Other Costs: Depreciation Charges, General Sales and Admin Cost |
| Currency | US$ (Data can also be provided in the local currency) |
| Pricing and Purchase Options | Basic: US$ 2499 Premium: US$ 3499 Enterprise: US$ 4799 |
| Customization Scope | The report can be customized as per the requirement of the customer |
| Post-Sale Analysts Report | 10-12 weeks of post-purchase analyst support after report delivery for any queries from the deliverable |
| Delivery Format | PDF and Excel format through email (editable version in PPT/Word format of the report can be also provided on special request) |
At Procurement Resource, we not only focus on optimising the should cost of production for oteseconazole but also provide our clients with extensive intel and rigorous information on every aspect of the production process. By utilising a comprehensive cost model, we help you break down expenses related to raw materials, labour, and technology, offering clear pathways to savings. We also assist in evaluating the capital expenditure (CAPEX) and operating expenses (OPEX), which are often measured as cost per unit of production, such as USD/MT, ensuring that your financial planning is aligned with industry benchmarks.
We offer valuable insights on the top technology providers, in-depth supplier database, and best manufacturers, helping you make informed decisions to improve efficiency. Additionally, we design the most feasible layout for your production needs, ensuring the entire process runs smoothly. By minimising the cash cost of production, we ensure that you stay competitive while securing long-term profitability in the growing oteseconazole market. Partnering with Procurement Resource guarantees that every aspect of your production is cost-efficient, advanced, and tailored to your specific requirements.
Lead - Social & Development Research
Delivering procurement intelligence and supply chain analytics across healthcare, FMCG, and chemicals sectors, with expertise in cost modeling, vendor mapping, and spend optimization to support data-driven sourcing decisions and procurement outcomes.
Need more help?
Still Need Help?
